Products
Platform
Research
Market
Learn
Compare Tata India Pharma & Healthcare Fund vs UTI Healthcare Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 3.0 | 4.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 2.1 | 2.26 |
NAV | ₹30.20 | ₹284.71 |
Fund Started | 04 Dec 2015 | 01 Aug 2005 |
Fund Size | ₹1338.85 Cr | ₹1126.13 Cr |
Exit Load | Exit load of 0.25% if redeemed within 30 days. | Exit load of 1% if redeemed within 30 days. |
Risk
Very High
Very High
Rating
3.0
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.1
2.26
NAV
₹30.20
₹284.71
Fund Started
04 Dec 2015
01 Aug 2005
Fund Size
₹1338.85 Cr
₹1126.13 Cr
Exit Load
Exit load of 0.25% if redeemed within 30 days.
Exit load of 1% if redeemed within 30 days.
Returns
1 Year | -1.65% | -2.35% |
3 Year | 21.79% | 23.57% |
5 Year | 15.70% | 15.50% |
1 Year
-1.65%
-2.35%
3 Year
21.79%
23.57%
5 Year
15.70%
15.50%
Holding Analysis
Equity | 98.47% | 98.12% |
Cash | 1.53% | 1.87% |
Equity
98.47%
98.12%
Cash
1.53%
1.87%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 9.59% |
Apollo Hospitals Enterprise Ltd. | 5.13% |
Healthcare Global Enterprises Ltd. | 4.96% |
Lupin Ltd. | 4.90% |
Max Healthcare Institute Ltd. | 4.71% |
Torrent Pharmaceuticals Ltd. | 4.52% |
Alkem Laboratories Ltd. | 4.42% |
Abbott India Ltd. | 4.02% |
Cipla Ltd. | 3.92% |
Ipca Laboratories Ltd. | 3.56% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 9.77% |
Ajanta Pharma Ltd. | 6.25% |
Lupin Ltd. | 5.58% |
Glenmark Pharmaceuticals Ltd. | 4.12% |
Cipla Ltd. | 3.74% |
Procter & Gamble Health Ltd. | 3.67% |
Gland Pharma Ltd. | 3.65% |
Apollo Hospitals Enterprise Ltd. | 3.62% |
Dr. Reddy's Laboratories Ltd. | 3.57% |
Alkem Laboratories Ltd. | 3.52% |
Fund Manager
Name | Meeta Shetty | Kamal Gada |
Start Date | 11 Nov 2024 | 02 May 2022 |
Name
Meeta Shetty
Kamal Gada
Start Date
11 Nov 2024
02 May 2022
About Fund
Description | The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India. | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. |
Launch Date | 04 Dec 2015 | 01 Aug 2005 |
Description
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Launch Date
04 Dec 2015
01 Aug 2005